Roger Hesselstrand

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Understanding patient-reported disease burden in systemic sclerosis: key clinical and demographic features revealed by the EULAR Systemic Sclerosis Impact of Disease (ScleroID) Questionnaire.

Understanding patient-reported disease burden in systemic sclerosis: key clinical and demographic features revealed by the EULAR Systemic Sclerosis Impact of Disease (ScleroID) Questionnaire.

Journal: EULAR rheumatology open

Published: August 01, 2026

Elevated pro-BNP and low-grade inflammation are associated with low bone mineral density in systemic sclerosis, a case control study.

Elevated pro-BNP and low-grade inflammation are associated with low bone mineral density in systemic sclerosis, a case control study.

Journal: Arthritis research & therapy

Published: May 12, 2026

Plasma GDF-15 and PSP-D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis.

Plasma GDF-15 and PSP-D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis.

Journal: Pulmonary circulation

Published: October 06, 2025

Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis.

Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis.

Journal: RMD open

Published: June 13, 2024

Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based study.

Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based study.

Journal: RMD open

Published: May 14, 2024

Increased prevalence of osteopenia and osteoporosis in systemic sclerosis patients, including in men and young women-a case-control study.

Increased prevalence of osteopenia and osteoporosis in systemic sclerosis patients, including in men and young women-a case-control study.

Journal: Rheumatology (Oxford, England)

Published: April 08, 2024

Corrigendum to "Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study" [Seminars in Arthritis and Rheumatism 53 (2022), 151978].

Corrigendum to "Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study" [Seminars in Arthritis and Rheumatism 53 (2022), 151978].

Journal: Seminars in arthritis and rheumatism

Published: November 18, 2023

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study.

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study.

Journal: Arthritis research & therapy

Published: June 25, 2023

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension.

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension.

Journal: Pulmonary circulation

Published: January 24, 2023

Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota.

Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota.

Journal: ACR open rheumatology

Published: December 21, 2022

Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis.

Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: October 13, 2022

Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.

Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.

Journal: Lupus science & medicine

Published: May 12, 2022

Showing 1-12 of 131

Last Updated: 09/26/2026